Document Details
Form
Filing Date
Sep 05, 2024
Document Date
Sep 03, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
HASSAN FRED
